SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6.90 |
Enterprise Value ($M) | 5.05 |
Book Value ($M) | 4.06 |
Book Value / Share | 0.24 |
Price / Book | 1.70 |
NCAV ($M) | 3.70 |
NCAV / Share | 0.22 |
Price / NCAV | 1.87 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.28 |
Return on Assets (ROA) | -0.63 |
Return on Equity (ROE) | -0.95 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.37 |
Current Ratio | 5.37 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.59 |
Assets | 5.95 |
Liabilities | 1.90 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -5.89 |
Net Income | -6.59 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -5.58 |
Cash from Investing | -2.83 |
Cash from Financing | 2.57 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | AFH Holding & Advisory, LLC | 3.80 | -52.67 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,121 | 23,459 | 34.62 | |
8,114 | 18,828 | 43.10 | |
2,786 | 19,471 | 14.31 | |
4,091 | 3,933 | 104.02 | |
(click for more detail) |
Similar Companies | |
---|---|
SBFM – Sunshine Biopharma, Inc. | SCLX – Scilex Holding Company |
SEEL – Seelos Therapeutics, Inc. | SLRX – Salarius Pharmaceuticals, Inc. |
SLS – SELLAS Life Sciences Group, Inc. |
Financial data and stock pages provided by
Fintel.io